Open navigation
Search
Offices – Germany
Explore all Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Search
Expertise
Insights

CMS lawyers can provide future-facing advice for your business across a variety of specialisms and industries, worldwide.

Explore topics
Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
CMS Germany Abroad
Insights
About CMS

Select your region

Deals 18 Jan 2022 · Germany

Series B financing round: CMS advises US tech company Bruker Corporation on acquisition of stake in PreOmics

2 min read

On this page

Frankfurt/Main – PreOmics GmbH, which is headquartered in Martinsried near Munich, has raised EUR 13.5 million in a Series B round of financing from Bruker Corporation, a NASDAQ-listed US tech company in the analytical instrumentation sector. PreOmics is a developer of innovative automation and sample preparation tools and consumables for proteomics analysis by mass spectrometry. Proteomics relates to analysis of the proteins that are active in a cell under certain conditions. Therapeutic approaches based on protein analysis are thought to offer great potential for developing new active agents, e.g. to fight cancer or infections.

In a parallel secondary transaction linked to the financing round, Bruker acquired the stakes held by several PreOmics investors, such as High-Tech Gründerfonds (HTGF), Think.Health Ventures and certain business angels. Bruker thus now holds a majority of the shares in PreOmics. Financial details of the secondary transaction were not disclosed.

A CMS team headed by lead partner Dr Hendrik Hirsch advised Bruker on all legal aspects of exclusive participation in the Series B round of financing, including the secondary transaction. Bruker Corporation is a longstanding client of CMS Germany and has been advised by CMS on several acquisitions and disposals in the past.

CMS Germany

Dr Hendrik Hirsch, Lead Partner, Frankfurt/Main
Dr Jessica Mohaupt-Schneider, Partner, Munich
Dr Tilman Weichert, Partner, Munich
Dr Berrit Roth-Mingram, Senior Associate, Frankfurt/Main
Maxine Notstain, Senior Associate, Frankfurt/Main
Maximilian Stark, Associate, Frankfurt/Main, all Corporate/M&A
Dr Thomas Hirse, Partner, Düsseldorf
Philippe Heinzke, Partner, Düsseldorf
Sven Krause, Senior Associate, Düsseldorf
Jan Nicolas Rajko, Senior Associate, Düsseldorf, all Intellectual Property
Dr Tobias Polloczek, Partner, Frankfurt/Main
Dr Theresa Kipp, Associate, Frankfurt/Main, both Labor, Employment & Pensions
Kai Neuhaus, Partner, Brussels
Moritz Pottek, Senior Associate, Brussels, both Competition & EU
Dr Roland Wiring, Partner, Hamburg
Dr Elisa Fontaine, Senior Associate, Hamburg, both Regulatory
Jörg Schrade, Partner, Munich, Tax
Dr Reemt Matthiesen, Partner, Munich, TMC
Charlotte Salathé, Senior Associate, Frankfurt/Main, Banking & Finance
Nicole Köppen, Senior Associate, Frankfurt/Main, Real Estate & Public

Press Contact
presse@cms-hs.com

Back to top